Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by inthnoon Sep 14, 2023 9:35am
238 Views
Post# 35635681

How much does the investor own

How much does the investor own

What Must I Do if I Become a 10% or Greater Shareholder?

What you have to do when you become a 10% or greater shareholder depends on whether or not you are an eligible institutional investor. If you are, then unless you are disqualified,you are eligible to use Canada’s alternative monthly reporting system (AMR). You will have to file your initial AMR report with the Canadian securities regulators within 10 days of becoming a 10% shareholder. After that, you will only need to file another AMR report within 10 days of the end of any month in which your ownership position, measured at month end, has increased or decreased by more than 2.5% from the last reported position or decreased below 10%. As an eligible institutional investor, you will also be exempt from Canada’s insider reporting requirements unless you are disqualified from the insider reporting exemption.

<< Previous
Bullboard Posts
Next >>